Skip to main content
. 2018 Nov 13;9:1214. doi: 10.3389/fphar.2018.01214

FIGURE 2.

FIGURE 2

In vitro anti-cancer efficacy of PEG-PLA, ELTN, FDTN, ELTN+FDTN (free drug), ELTN@PEG-PLA, FDTN@PEG-PLA, and ELTN+FDTN@PEG-PLA in H1975 (A) and H1650 (B) cells at various drug concentrations following 48-h incubation (n = 3).